Cognyte Software (CGNT)
(Delayed Data from NSDQ)
$7.01 USD
+0.16 (2.34%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $7.02 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.01 USD
+0.16 (2.34%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $7.02 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Zacks News
NxStage System One Gets FDA Nod for Solo Home Hemodialysis
by Zacks Equity Research
The latest regulatory go-ahead is likely to lend NxStage (NXTM) a competitive edge and expand its patient base with solid access to the clinical benefits associated with home hemodialysis.
Zacks.com featured highlights Summer Infant, Intra-Cellular Therapies, PDL BioPharma, Cogentix Medical and Intrepid Potash
by Zacks Equity Research
Zacks.com featured highlights Summer Infant, Intra-Cellular Therapies, PDL BioPharma, Cogentix Medical and Intrepid Potash
Veeva Systems (VEEV) Beats Q2 Earnings, Revenue Estimates
by Zacks Equity Research
Veeva Systems (VEEV) witnessed stellar numbers in the second quarter owing to strong adoption of products like Veeva Network, Veeva Align, Veeva OpenData and Veeva CRM Approved Email.
5 Bargain Breakout Stocks Offering Stunning Returns
by Swarup Gupta
The key to this kind of stock selection is to identify players that are trading within a narrow band.
Stryker Recalls Sage Unit Products, Guidance Takes a Hit
by Zacks Equity Research
Added to the voluntary recall, Stryker (SYK) also placed a temporary hold on certain cloth-based products. Share price of Stryker declined massively following the news.
Patterson Companies (PDCO) Beats on Q1 Earnings, Keeps View
by Zacks Equity Research
Patterson Companies' (PDCO) Animal Health business continues to contribute to the bottom line. Stable fiscal 2018 guidance instills investor confidence.
Civitas Solutions (CIVI) to Acquire Habilitative Services
by Zacks Equity Research
Civitas Solutions' (CIVI) proposed acquisition of Habilitative Services will aid the company in capturing the lucrative Minnesota market.
Accuray (ARAY) Q4 Loss Wider Than Expected, Revenues Beat
by Zacks Equity Research
Accuray's (ARAY) new TomoTherapy product platform, also known as Radixact, continues to contribute to the top line. Solid Fiscal 2018 guidance instills investor confidence.
PerkinElmer Strong on Product Lineup Amid Integration Risks
by Zacks Equity Research
PerkinElmer's (PKI) expanding product portfolio helps it gain global market share. However, the company's regular acquisitions pose integration risks.
Will Cogentix Medical (CGNT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Cogentix Medical Inc (CGNT)
Cogentix (CGNT) Looks Good: Stock Moves Up 5.2% in Session
by Zacks Equity Research
Cogentix Medical, Inc. (CGNT) moved big mover last session, as its shares rose over 5% on the day.
New Strong Sell Stocks for March 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Why Trump Could Still Be a Threat to Medical Device Stocks
by Zacks Equity Research
The Republican healthcare bill, American Health Care Act (ACHA), which was released earlier this month with the target to repeal the Affordable Care Act (ACA), hasn't found favor with the masses.
Owens & Minor (OMI) Reaffirms Tepid 2017 Financial Guidance
by Zacks Equity Research
Owens & Minor Inc. (OMI) outlined its new strategic plan and reaffirmed the financial guidance.
TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4
by Zacks Equity Research
TrovaGene Inc. (TROV) reported loss of 31 cents per share in the fourth quarter of 2016, 2 cents wider than the Zacks Consensus Estimate.
Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Cogentix Medical, Inc. (CGNT) reported adjusted loss of 14 cents per share in the fourth quarter of 2016.
Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance
by Zacks Equity Research
Luminex Corporation (LMNX) announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for full-year 2016.
PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics
by Zacks Equity Research
PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.
Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels
by Zacks Equity Research
Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.
Air Methods (AIRM): Winter Hits December Passenger Count
by Zacks Equity Research
Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.
AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View
by Zacks Equity Research
AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.
Cerner Extends HNM Partnership with University of Missouri
by Zacks Equity Research
Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.
Alere Forensic Toxicology Division Gets ABFT Accreditation
by Zacks Equity Research
Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.
Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay
by Zacks Equity Research
Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.
Mazor Robotics (MZOR) Receives 21 System Orders in Q4
by Zacks Equity Research
Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.